Senseonics schedules November 9 results. Senseonics stock gains 1.52 percent
Published on 10/24/2026 at 18:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date and analyst view
- Senseonics scheduled its third-quarter earnings release for November 9, 2026, at 4:30 p.m. ET.
- Stifel Nicolaus maintained a USD 9.00 target and Hold rating on October 8, 2026.
- Senseonics stock costs EUR 6.70 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST, 1.52 percent above the Tradegate close and 27.57 percent below its 52-week high.
Senseonics Holdings (ISIN US81727U3032) scheduled its third-quarter 2026 earnings release for November 9, 2026, at 4:30 p.m. ET, according to the Senseonics investor-relations calendar dated October 21, 2026. The stock was trading at EUR 6.70 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST, up 1.52 percent versus the Tradegate close of October 22, 2026 at EUR 6.60.
Analyst target remains above Nasdaq price
Stifel Nicolaus maintained a Hold rating and a USD 9.00 price target in a report dated October 8, 2026, as reported by Markets Insider. Senseonics last traded at USD 7.51 on Nasdaq on October 23, 2026 at 4:00 p.m. EDT, putting the Stifel target 19.71 percent above that price.
Stock remains below its yearly high
The euro quote stood 27.57 percent below the Tradegate 52-week high of EUR 9.25 and 61.84 percent above the low of EUR 4.14, both dated October 22, 2026. The same Tradegate page put the company's market capitalization at EUR 343.7 million on that date and reported a 32.00 percent gain for the year.
Results date sets the next marker
The November 9 release will provide the next scheduled checkpoint for Eversense, Senseonics' implantable continuous glucose monitoring system. The company describes sensors lasting up to 90 days for Eversense and up to 180 days for Eversense XL on its investor-relations page. The scheduled release date is the clearest near-term event for the stock.
Comparison with peers
Senseonics: up 1.52 percent versus the Tradegate close, market capitalization EUR 343.7 million. DexCom (Nasdaq, USD): down 0.49 percent, P/E 30.81, market capitalization USD 29.4 billion. Insulet (Nasdaq, USD): up 0.60 percent, P/E 27.85, market capitalization USD 10.3 billion.
Price and scheduled event
The November reporting date gives investors a defined event after a 32.00 percent year-to-date gain and a 27.57 percent gap to the Tradegate 52-week high. Senseonics stock was trading at EUR 6.70 at Lang & Schwarz on October 24, 2026 at 1:04 p.m. CEST, 1.52 percent above the Tradegate close of October 22, 2026 at EUR 6.60. The further course of trading is shown by the continuously updated real-time quote of Senseonics stock.
Senseonics Holdings at a glance
- Company: Senseonics Holdings, Inc.
- ISIN: US81727U3032
- Ticker: SENS
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 24, 2026, 1:04 p.m. CEST): EUR 6.70
- Change versus Tradegate close: plus 1.52 percent
- Tradegate close (October 22, 2026): EUR 6.60
- Market capitalization: USD 397.1 million (as of October 23, 2026)
- 52-week range: EUR 4.14-9.25 (as of October 22, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: November 9, 2026
Market context: Market report S&P 500.
